Parametric Portfolio Associates’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
ACH
Parametric Portfolio Associates's VCYT Position: Q1 2022 in Review
Parametric Portfolio Associates reduced its Veracyte (VCYT) stake by 13% in Q1 2022, selling an estimated $286K and leaving 67,918 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2456.
Parametric Portfolio Associates first reported a position in VCYT in Q4 2016 and has held it in 18 quarters since. The position peaked at $5.66M in Q4 2020. 205 funds tracked by Wall St. Rank hold VCYT as of Q1 2022.
- Parametric Portfolio Associates held 67,918 shares of Veracyte worth $1.87M as of Q1 2022.
- Parametric Portfolio Associates sold 10,011 Veracyte shares in Q1 2022, an estimated $286K.
- Veracyte made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2456 holding.
- Parametric Portfolio Associates first reported a position in Veracyte in Q4 2016 and has held it in 18 quarters since.
- Parametric Portfolio Associates's Veracyte position peaked at $5.66M in Q4 2020.
- 205 funds tracked by Wall St. Rank held Veracyte as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.